LabCompass

Guanglong Jiang

Medicine · Indiana University

OpenAlex ORCID
Cancer Treatment and PharmacologyBreast Cancer Treatment StudiesPARP inhibition in cancer therapyEpigenetics and DNA MethylationLung Cancer Treatments and Mutations

Publications

188

Citations

2,401

Est. group size

~1

Recurring co-author estimate

Active years

23

Publishing since 2004

Research summary
AI-generated

Guanglong Jiang works in cancer research with a focus on the molecular and genomic features of tumors, including breast, ovarian, and urothelial (urinary tract) cancers. Much of the work involves analyzing DNA methylation (chemical marks on genes), gene expression, and biomarkers to understand drug resistance and predict treatment response. Some studies also examine health outcomes and disparities in cancer patients.

Cancer genomics and epigeneticsDrug resistance in cancer (e.g., platinum, carboplatin)Biomarker discovery for cancer treatmentComputational analysis of sequencing dataBreast and ovarian cancer studies

Publication activity has been variable over the decade, with a large spike in 2023 and a return to more modest output (around 7-11 papers per year) in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 19.2/year recently
2017: 12 publications172018: 11 publications182019: 7 publications192020: 18 publications202021: 13 publications212022: 8 publications222023: 59 publications59232024: 11 publications242025: 11 publications252026: 7 publications26
Recent publications
Publishes in
  • Cancer Research×17
  • Journal of Clinical Oncology×9
  • PMC×7
  • Scientific Reports×5
  • Nature Communications×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile